InvestorsHub Logo
Followers 5
Posts 280
Boards Moderated 0
Alias Born 08/29/2015

Re: Kentucky123 post# 170053

Saturday, 10/27/2018 6:50:47 PM

Saturday, October 27, 2018 6:50:47 PM

Post# of 459541
Posted by Andy Bio on Twitter
Treatment did worse in phase 2 vs placebo looks like they gleaned information from a sub group to come up with this result.
$GRFS long-awaited AMBAR data at #CTAD2018 (link: https://www.prnewswire.com/news-releases/grifols-demonstrates-a-significant-reduction-61-in-the-progression-of-moderate-alzheimers-disease-using-its-ambar-treatment-protocol-300738956.html) prnewswire.com/news-releases/… Claims to hit in moderate but not mild pts - ADAS-Cog p=0.05 shouldn't be stat sig w/ multiplicity adj. - ADCS-ADL p=0.002 but in previous Ph2 actually did worse than pbo - Need full baseline characteristics etc
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News